[
    [
        {
            "time": "2019-02-01",
            "original_text": "医药生物行业2019年2月月报:政策明朗,兼顾安全与成长性",
            "features": {
                "keywords": [
                    "医药生物",
                    "政策明朗",
                    "安全性",
                    "成长性"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 2
            }
        }
    ]
]